A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence
- Christianne L. Roumie, MD;
- Eric L. Grogan, MD;
- William Falbe, PharmD;
- Joseph Awad, MD;
- Theodore Speroff, PhD;
- Robert S. Dittus, MD, MPH; and
- Tom A. Elasy, MD, MPH
-
From Veterans Administration Tennessee Valley Healthcare System and Vanderbilt University, Nashville, Tennessee.
-
Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Study timeline.
-
Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Discontinuation of hormone replacement therapy (HRT).
-
Appendix Figure 1. Provider education e-mail.
-
Appendix Figure 2. Patient education letter.
-
Appendix Figure 3. Pharmacy alert.
-
Ann Intern Med
July 20, 2004
vol. 141
no. 2
118-125
RSS Feeds
Figure 1. ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Study timeline.
Figure 2. Hazard ratio, 4.9 (95% CI, 1.8 to 13.1). ACY = Alvin C. York Medical Center; CBOC = community-based outpatient center. Discontinuation of hormone replacement therapy (HRT).
Appendix Figure 1. Provider education e-mail.
Appendix Figure 2. Patient education letter.
Appendix Figure 3. Pharmacy alert.
Related Clinical Content
